CHARITY NOBLE: Open Payments
NPI 1649799214 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 54 payments from 13 companies in 2025. Trend: 2023 $18 · 2024 $678 · 2025 $1,169
Food & beverage: $1,070Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $319 |
| Lilly USA, LLC | 10 | $257 |
| Novo Nordisk Inc | 5 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $111 |
| Astellas Pharma US Inc | 1 | $99 |
| PFIZER INC. | 3 | $61 |
| Corcept Therapeutics | 1 | $44 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Exact Sciences Corporation | 1 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
Products named: UBRELVY, MOUNJARO, TRINTELLIX, ZEPBOUND, Ozempic, VRAYLAR, QULIPTA, Korlym.
Industry payments across TX — which companies pay providers there.
